198 related articles for article (PubMed ID: 19714721)
1. Re-treating chronic hepatitis C with daily interferon alfacon-1/ribavirin after nonresponse to pegylated interferon/ribavirin: really safe and effective?
Lo GH
Hepatology; 2009 Sep; 50(3):988; author reply 988-9. PubMed ID: 19714721
[No Abstract] [Full Text] [Related]
2. Hepatitis C: CIFN for re-treatment of PEG-IFN plus RBV nonresponders?
Trepo C; Pradat P
Nat Rev Gastroenterol Hepatol; 2009 Oct; 6(10):570-1. PubMed ID: 19789573
[No Abstract] [Full Text] [Related]
3. Treatment options for patients with chronic hepatitis C not responding to initial antiviral therapy.
Jacobson IM
Clin Gastroenterol Hepatol; 2009 Sep; 7(9):921-30. PubMed ID: 19362605
[No Abstract] [Full Text] [Related]
4. Retreating chronic hepatitis C with daily interferon alfacon-1/ribavirin after nonresponse to pegylated interferon/ribavirin: DIRECT results.
Bacon BR; Shiffman ML; Mendes F; Ghalib R; Hassanein T; Morelli G; Joshi S; Rothstein K; Kwo P; Gitlin N
Hepatology; 2009 Jun; 49(6):1838-46. PubMed ID: 19291790
[TBL] [Abstract][Full Text] [Related]
5. [The role and possibilities of natural interferon treatment in chronic hepatitis C: experience with natural interferon treatment for patients barred from combined antiviral therapy because of the STOP rule].
Horváth G; Tolvaj G; Halász T; Stotz G
Orv Hetil; 2007 Aug; 148(33):1545-50. PubMed ID: 17686672
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of chronic hepatitis C relapse].
Olivé G; Buti M; Esteban-Mur R; Guardia J
Gastroenterol Hepatol; 2000 Feb; 23 Suppl 1():47-50. PubMed ID: 11968344
[No Abstract] [Full Text] [Related]
7. [Interferon in the treatment of viral hepatitis. The interferon was discovered 50 years ago].
Fehér J; Lengyel G
Orv Hetil; 2007 Aug; 148(33):1539-43. PubMed ID: 17686671
[TBL] [Abstract][Full Text] [Related]
8. Induction therapy in chronic hepatitis C: déjà-vu with pegylated interferons?
Zeuzem S
J Hepatol; 2004 Sep; 41(3):488-90. PubMed ID: 15336454
[No Abstract] [Full Text] [Related]
9. Successful treatment with novel triple drug combination consisting of interferon-gamma, interferon alfacon-1, and ribavirin in a nonresponder HCV patient to pegylated interferon therapy.
Balan V; Rosati MJ; Anderson MH; Rakela J
Dig Dis Sci; 2006 May; 51(5):956-9. PubMed ID: 16758306
[TBL] [Abstract][Full Text] [Related]
10. [Experiences in antiviral treatment of chronic viral hepatitis B and C in Hungary (1998-2004)].
Pár A; Tornai I; Szalay F
Orv Hetil; 2007 May; 148(18):819-26. PubMed ID: 17468063
[TBL] [Abstract][Full Text] [Related]
11. 1990-2010: two decades of interferon-based therapy.
Buti M; Esteban R
Clin Liver Dis; 2011 Aug; 15(3):473-82. PubMed ID: 21867931
[TBL] [Abstract][Full Text] [Related]
12. [Pegylated interferon α-2a and ribavirin antiviral therapy efficacy for treating chronic hepatitis C and its effects on psychological status of patients].
An J; Qiao J; Ni W
Zhonghua Gan Zang Bing Za Zhi; 2014 Oct; 22(10):772-3. PubMed ID: 25558497
[No Abstract] [Full Text] [Related]
13. [Interferons alpha in the treatment of chronic HCV infections].
Halota W; Pawłowska M; Andrejczyn M
Przegl Epidemiol; 2004; 58(3):405-11. PubMed ID: 15730004
[TBL] [Abstract][Full Text] [Related]
14. Use of pegylated interferons is associated with an increased incidence of infections during combination treatment of chronic hepatitis C: a side effect of pegylation?
Puoti M; Babudieri S; Rezza G; Viale P; Antonini MG; Maida I; Rossi S; Zanini B; Putzolu V; Fenu L; Baiguera C; Sassu S; Carosi G; Mura MS
Antivir Ther; 2004 Aug; 9(4):627-30. PubMed ID: 15456094
[TBL] [Abstract][Full Text] [Related]
15. Chronic hepatitis C in HIV-infected patients: low eligibility and applicability of therapy with pegylated interferon-alpha plus ribavirin.
Rauch A; Egger M; Reichen J; Furrer H;
J Acquir Immune Defic Syndr; 2005 Feb; 38(2):238-40. PubMed ID: 15671812
[No Abstract] [Full Text] [Related]
16. Pegylated interferon alpha-2a plus low-dose ribavirin for the retreatment of dialysis chronic hepatitis C patients who relapsed from prior interferon monotherapy.
Liu CH; Liang CC; Liu CJ; Tsai HB; Hung PH; Hsu SJ; Chen SI; Lin JW; Lai MY; Chen JH; Chen PJ; Chen DS; Kao JH
Gut; 2009 Feb; 58(2):314-6. PubMed ID: 19136527
[No Abstract] [Full Text] [Related]
17. Management of chronic hepatitis C patients who have relapsed or not responded to pegylated interferon alfa plus ribavirin.
Dieterich DT; Rizzetto M; Manns MP
J Viral Hepat; 2009 Dec; 16(12):833-43. PubMed ID: 19889142
[TBL] [Abstract][Full Text] [Related]
18. Viral dynamics and prediction of response to treatment with pegylated interferon and ribavirin in patients with chronic hepatitis C.
Aguilar Reina J
Rev Esp Enferm Dig; 2009 Oct; 101(10):665-70. PubMed ID: 19899934
[No Abstract] [Full Text] [Related]
19. Peginterferon and ribavirin for hepatitis C.
Abramowicz M
N Engl J Med; 2007 Mar; 356(12):1270-1; author reply 1271. PubMed ID: 17378100
[No Abstract] [Full Text] [Related]
20. Treatment of chronic hepatitis C patients with combination of alpha-interferon and ribavirin, consensus and pegylated interferons.
Husa P; Husova L
Bratisl Lek Listy; 2001; 102(5):248-52. PubMed ID: 11725377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
